BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17035234)

  • 1. Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.
    Rizos H; McKenzie HA; Ayub AL; Woodruff S; Becker TM; Scurr LL; Stahl J; Kefford RF
    J Biol Chem; 2006 Dec; 281(49):38080-8. PubMed ID: 17035234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.
    Itahana K; Bhat KP; Jin A; Itahana Y; Hawke D; Kobayashi R; Zhang Y
    Mol Cell; 2003 Nov; 12(5):1151-64. PubMed ID: 14636574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
    Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
    Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT1 promotes the tumor suppressor function of p14
    Repenning A; Happel D; Bouchard C; Meixner M; Verel-Yilmaz Y; Raifer H; Holembowski L; Krause E; Kremmer E; Feederle R; Keber CU; Lohoff M; Slater EP; Bartsch DK; Bauer UM
    EMBO J; 2021 Jul; 40(13):e106777. PubMed ID: 33999432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I.
    Lessard F; Morin F; Ivanchuk S; Langlois F; Stefanovsky V; Rutka J; Moss T
    Mol Cell; 2010 May; 38(4):539-50. PubMed ID: 20513429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
    Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.
    Rizos H; Darmanian AP; Holland EA; Mann GJ; Kefford RF
    J Biol Chem; 2001 Nov; 276(44):41424-34. PubMed ID: 11518711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
    Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
    Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p14(ARF) regulates E2F activity.
    Mason SL; Loughran O; La Thangue NB
    Oncogene; 2002 Jun; 21(27):4220-30. PubMed ID: 12082609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.
    Sugimoto M; Kuo ML; Roussel MF; Sherr CJ
    Mol Cell; 2003 Feb; 11(2):415-24. PubMed ID: 12620229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways.
    Sánchez-Aguilera A; Sánchez-Beato M; García JF; Prieto I; Pollan M; Piris MA
    Blood; 2002 Feb; 99(4):1411-8. PubMed ID: 11830494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino terminal hydrophobic import signals target the p14(ARF) tumor suppressor to the mitochondria.
    Irvine M; Philipsz S; Frausto M; Mijatov B; Gallagher SJ; Fung C; Becker TM; Kefford RF; Rizos H
    Cell Cycle; 2010 Feb; 9(4):829-39. PubMed ID: 20107316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations.
    Olcha P; Cybulski M; Skomra D; Obrzut B; Ignatov A; Jóźwik M; Schneider-Stock R; Semczuk A
    Int J Gynecol Cancer; 2010 Aug; 20(6):993-9. PubMed ID: 20683407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism.
    Rizos H; Scurr LL; Irvine M; Alling NJ; Kefford RF
    Cell Cycle; 2007 Jul; 6(14):1741-7. PubMed ID: 17630509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
    Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
    Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
    Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor β1 (TGF-β1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53.
    Chen G; Ghosh P; O'Farrell T; Munk R; Rezanka LJ; Sasaki CY; Longo DL
    J Biol Chem; 2012 Jun; 287(27):23184-95. PubMed ID: 22621932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas.
    Wang P; Rao J; Yang H; Zhao H; Yang L
    J Surg Oncol; 2011 Nov; 104(6):679-84. PubMed ID: 21695702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
    Bertwistle D; Sugimoto M; Sherr CJ
    Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p14(ARF) inhibits the functions of adenovirus E1A oncoprotein.
    Shen J; Zhang S; Li Y; Zhang W; Chen J; Zhang M; Wang T; Jiang L; Zou X; Wong J; Li X; Cui Y; Wang C
    Biochem J; 2011 Mar; 434(2):275-85. PubMed ID: 21133853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.